Family

Loading Family data...

• 15 United States
• 10 France
• 8 Japan
• 7 China
• 5 Korea
• 2 Other

Patent Owner(s)

Patent Owner	Address
AVENTIS PHARMA S A	1 TERRASSE BELLINI 9800 PUTEAUX

International Classification(s)

• A61K:PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOS....

• 2012 Application Filing Year
• A61K Class
• 11964 Applications Filed
• 9694 Patents Issued To-Date
• 81.03 % Issued To-Date

Inventor(s)

Inventor Name	Address	# of filed Patents	Total Citations
DESTREE, Dominique	Paris, FR	4	0
# of filed Patents : 4 Total Citations : 0
JEAN, DE POTTER Chantal	Paris, FR	2	0
# of filed Patents : 2 Total Citations : 0

Cited Art Landscape

Load Citation

• No Cited Art to Display

Loading Cited Art Landscape...

Patent Citation Ranking

• 0 Citation Count
• A61K Class

• 0 % this patent is cited more than
• 12 Age

Forward Cite Landscape

Load Citation

• No Forward Cites to Display

Loading Forward Cite Landscape...

Maintenance Fees

Fee	Large entity fee	small entity fee	micro entity fee	due date

Fee	Large entity fee	small entity fee	micro entity fee
Surcharge after expiration - Late payment is unavoidable	$700.00	$350.00	$175.00
Surcharge after expiration - Late payment is unintentional	$1,640.00	$820.00	$410.00

Full Text

US Patent Application No: 2013/0102,566

SEMULOPARIN FOR USE AS AN ANTITHROMBOTIC TREATMENT IN HIP REPLACEMENT SURGERY WITH IMPROVED SAFETY IN TERMS OF CLINICALLY RELEVANT BLEEDINGS AND MAJOR BLEEDINGS

---

Abstract

---

The invention relates to the use of semuloparin or a pharmaceutically acceptable salt thereof as an antithrombotic treatment in patients undergoing hip replacement surgery, wherein said use involves an improved safety in terms of clinically relevant bleedings and of major bleedings compared to a standard antithrombotic treatment.

---

 

---

Description

---

Claims

---

Claims data not available

---

Legal Events

• No Legal Status data available.